This study investigated the role of H1 and H2 receptors in
anxiety and the retrieval of emotional memory using a Trial 1/Trial 2 (T1/T2)
protocol in an elevated plus-maze (EPM). Tests were performed on 2 consecutive
days, designated T1 and T2. Before T1, the mice received intraperitoneal
injections of saline (SAL), 20 mg/kg zolantidine (ZOL, an H2
receptor antagonist), or 8.0 or 16 mg/kg chlorpheniramine (CPA, an
H1 receptor antagonist). After 40 min, they were subjected
to the EPM test. In T2 (24 h later), each group was subdivided into two
additional groups, and the animals from each group were re-injected with SAL or
one of the drugs. In T1, the Student t-test showed no
difference between the SAL and ZOL or 8 mg/kg CPA groups with respect to
the percentages of open arm entries (%OAE) and open arm time
(%OAT). However, administration of CPA at the highest dose of
16 mg/kg decreased %OAE and %OAT, but not locomotor
activity, indicating anxiogenic-like behavior. Emotional memory, as revealed by
a reduction in open arm exploration between the two trials, was observed in all
experimental groups, indicating that ZOL and 8 mg/kg CPA did not affect
emotional memory, whereas CPA at the highest dose affected acquisition and
consolidation, but not retrieval of memory. Taken together, these results
suggest that H1 receptor, but not H2, is implicated in
anxiety-like behavior and in emotional memory acquisition and consolidation
deficits in mice subjected to EPM testing.